Alpha Tau Medical

DRTS · NASDAQ

$13.16+$0.26 (+2.02%)TodayMarket closed ·
Prev close $12.90

Who owns DRTS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 35.6% of DRTS’s shares.

  • Oramed Pharmaceuticals Inc15.6%
  • Sofer (Uzi)12.5%
  • Avruch (Michael)1.6%
  • Gem Investment Advisors, L.L.C.1.6%
  • Next 6 largest institutions4.3%
  • All other shareholders64.4%
Top institutional holders of DRTS
HolderShares% of shares
Oramed Pharmaceuticals Inc14.47M15.65%
Sofer (Uzi)11.52M12.45%
Avruch (Michael)1.52M1.64%
Gem Investment Advisors, L.L.C.1.43M1.55%
Hightower Advisors, LLC874.99K0.95%
Boothbay Fund Management, LLC773.48K0.84%
Aquamarine Financial (Cayman) Ltd721.50K0.78%
Pier Capital, LLC691.94K0.75%
Keisari (Yona)503.49K0.54%
UBS Switzerland AG399.53K0.43%

Largest mutual fund holders

Top mutual fund holders of DRTS
HolderShares% of shares
SEB Choice Nordamerika Smabolagsfond275.00K0.30%
Florida State Board Administration Fund198.61K0.21%
ARK Israel Innovative Technology ETF184.38K0.20%
Adara Smaller Companies Fund129.36K0.14%
Dunham Small Cap Growth Fund71.66K0.08%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.56M (12 trades) of DRTS on the open market, with no buys.

Latest DRTS insider transactions
InsiderTypeSharesValue
Levy RaphiSale2.87K$43.07K
Levy RaphiOption exercise2.87K$8.56K
Levy RaphiSale17.73K$248.28K
Levy RaphiOption exercise17.73K$52.84K
Levy RaphiSale2.27K$31.78K
Levy RaphiOption exercise2.27K$6.76K
Levy RaphiSale17.87K$232.40K
Levy RaphiOption exercise17.87K$53.26K
Levy RaphiSale2.13K$27.69K
Levy RaphiOption exercise2.13K$6.34K

Short interest

Settled Sep 30, 2026

Shares short
3.45M
Days to cover
6.63
% of shares outstanding
3.73%
Average daily volume
519.90K
Change since last report
−1.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.